In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other stocks that Jim Cramer discusses. On Wednesday, Jim Cramer, the host of Mad Money ...

Information About Us Contact us Feedback Terms Of Service Privacy Policy Subscriber Agreement JPost Jobs Cancel Subscription Sitemap Customer Service JP Store ...

During Google's latest earnings call, Google CFO Anat Ashkenazi said: "We exited the year with more demand than we had available capacity. So, we are in a tight supply-demand situation, working very ...

An important but largely concealed CIA report, titled “Israel: The Sephardi-Ashkenazi Confrontation and Its Implications” is almost prophetic in its ability to detail future scenarios for a ...

today announced that Anat Ashkenazi, currently Executive Vice President and Chief Financial... Eli Lilly and Company (NYSE:LLY) announced today that Anat Ashkenazi has resigned as chief financial ...

April 2 (Reuters) - Primary care company knownwell said on Wednesday it will provide health and weight-management services on Eli Lilly's (LLY.N), opens new tab direct-to-consumer online ...

In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other best healthcare stocks to invest in. Healthcare stocks experienced a challenging year in ...

Eli Lilly and Novo Nordisk occupy leading positions in the obesity and diabetes markets, valued at more than $100 billion. Each of them has advantages, as well as dark spots in the pipeline of ...

The Eli Lilly drug caused a major drop in the blood levels of Lp(a), but further research is needed to show that it will prevent heart attacks and strokes. By Gina Kolata As many as one in five ...

In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other billionaire Ken Fisher’s top growth stock picks. “Who am I to tell you anything ...

The European Medicines Agency committee declined to approve Eli Lilly's Alzheimer’s treatment, citing risks of brain bleeding and swelling. The drug, Kisunla, has been approved in Japan, China, and by ...